6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed Mar 26, 2026 · 3mo ago · Accession 0001395064-26-000102
Plain English
Takeda announced proposed candidates for its Board of Directors, including CEO-elect Julie Kim as a new candidate, with current CEO Christophe Weber planning to retire. If elected, Julie Kim will be appointed Representative Director, President & CEO following the shareholders meeting on June 24, 2026.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- Mar 26, 2026
- Report date
- Mar 26, 2026
- Document
- form6k_032626.htm
- Size
- 63 KB